Mitigating effect of fermented Korean red ginseng extract with yeast and probiotics in 1-chloro-2,4-dinitrobenzene-induced skin allergic inflammation
Backgrounds Atopic dermatitis (AD) frequently affects both infants and adults, impacting on the quality of life of the individual and imposing a significant psychosocial burden. The efficacy against AD-like skin lesions of the fermented form of Korea red ginseng (FRG), that contains ginsenoside meta...
Saved in:
Published in | Molecular & cellular toxicology Vol. 15; no. 2; pp. 111 - 121 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Incheon
The Korean Society of Toxicogenomics and Toxicoproteomics
01.04.2019
Springer Nature B.V 대한독성 유전단백체 학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Backgrounds
Atopic dermatitis (AD) frequently affects both infants and adults, impacting on the quality of life of the individual and imposing a significant psychosocial burden. The efficacy against AD-like skin lesions of the fermented form of Korea red ginseng (FRG), that contains ginsenoside metabolites, has not been investigated.
Methods
FRG was prepared after fermentation of Korean red ginseng (KRG) extract in the presence of yeast and probiotics. The effects of FRG on skin allergic inflammation were then investigated by examining the frequency of scratching, and assessing the levels of representative allergic markers in 1-chloro-2,4-dinitrobenzene (DNCB)-challenged Balb/c mice. After two weeks of DNCB challenge, vehicle, dexamethasone (positive control), and FRG (10 and 50 μg/mL) were applied topically on skin lesions for 2 weeks. At the end of the experiment, scratching behavior, immunoglobulin E (IgE), and interleukin 4 (IL-4) levels were measured. The status of mitogen-activated protein kinases (MAPKs) and nuclear factor kappa B (NF-κB) were determined by immunoblot analysis in DNCB-treated primary splenocytes.
Results
Topical administration of FRG significantly suppressed scratching behavior, serum IgE, and IL-4 levels (
P
<0.05,
n
=5/group). In addition, FRG treatment significantly decreased the mRNA expression levels of IL-4 and IL-10 in DNCB-exposed splenocytes (
P
<0.05,
n
=6/group). Moreover, FRG suppressed DNCB-induced phosphorylation of p38 MAPK and activation of NF-κB.
Conclusion
FRG could ameliorate skin allergic inflammation via suppression of p38 MAPK and NF-κB. Therefore, FRG may be a potential therapeutic agent for the prevention and/or treatment of atopic-like dermatitis. |
---|---|
ISSN: | 1738-642X 2092-8467 |
DOI: | 10.1007/s13273-019-0014-z |